Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiana Pratticò

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|August 28, 2024
Focus on Pancreatic Cancer MicroenvironmentFabiana Pratticò, Ingrid Garajová
BMJ Supportive & Palliative Care|September 4, 2023
Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictorsAlessandro Leonetti, Marianna Peroni, Virginia Agnetti, et al.
Journal of Clinical Medicine|April 13, 2024
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment StrategiesChiara Tommasi, Giulia Airò, Fabiana Pratticò, et al.
Immunotherapy|September 16, 2020
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapyMelissa Bersanelli, Teresa Zielli, Fabiana Perrone, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|August 28, 2024
Focus on Pancreatic Cancer MicroenvironmentFabiana Pratticò, Ingrid Garajová
BMJ Supportive & Palliative Care|September 4, 2023
Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictorsAlessandro Leonetti, Marianna Peroni, Virginia Agnetti, et al.
Journal of Clinical Medicine|April 13, 2024
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment StrategiesChiara Tommasi, Giulia Airò, Fabiana Pratticò, et al.
Immunotherapy|September 16, 2020
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapyMelissa Bersanelli, Teresa Zielli, Fabiana Perrone, et al.
Pageof 1